(R)-2-Amino-N-(3-(benzyloxy)-1-(1-(methylsulfonyl)spiro[indoline-3,4'-piperidin]-1'-yl)-1-oxopropan-2-yl)-2-methylpropanamide methanesulfonate
N-(3-Chloro-4-(((2-(methylamino)-6-(pyridin-2-yl)pyrimidin-4-yl)amino)methyl)phenyl)methanesulfonamide
Tm-n1324
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide
(R)-2-(2-Methylimidazo[2,1-b]thiazol-6-yl)-1-(2-(5-(6-methylpyrimidin-4-yl)-2,3-dihydro-1H-inden-1-yl)-2,7-diazaspiro[3.5]nonan-7-yl)ethan-1-one
(S)-6-(4-Fluorophenoxy)-3-((1-isopropylpiperidin-3-yl)methyl)-2-methylquinazolin-4(3H)-one
TZP 101
1-(2-(2-Chloro-4-(2H-1,2,3-Triazol-2-yl)benzyl)-2,7-diazaspiro[3.5]nonan-7-yl)-2-(2-methylimidazo[2,1-b]thiazol-6-yl)ethanone
(S)-N-((2R,5S,8R,11S,14S)-8-((1H-Indol-3-yl)methyl)-5-benzyl-14-carbamoyl-11-isobutyl-16-methyl-1-(naphthalen-1-yl)-3,6,9,12-tetraoxo-4,7,10,13-tetraazaheptadecan-2-yl)-2,6-diaminohexanamide
BMS-604992 free base
YIL781 hydrochloride
BMS-604992
Ghrelin receptor full agonist-2
(R)-N'-(3,5-Bis(trifluoromethyl)phenyl)-2-((S)-hexahydropyrrolo[1,2-a]pyrazin-2(1H)-yl)-2-(pyridin-3-yl)acetohydrazide
K-(D-1-Nal)-FwLL-NH2 TFA
PF-6870961
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide hydrochloride
PF-6870961 hydrochloride
Rel-N-(5-((3R,5S)-3,5-dimethylpiperazin-1-yl)-2-methoxyphenyl)-3-fluoro-4-(5-methylfuran-2-yl)benzenesulfonamide
GSK894490A
